When testing the simultaneous effects of the mean methylation levels in the candidate genome regions together with depression and the clustered sociodemographic clinical data, GRM2 methylation was significantly and negatively associated with FM risk, while depression was positively associated with it. This evidence concerns the gene GRM2 and depressive symptom measurement.